Nanostellar

Synthego, located in Redwood City, CA, specializes in providing advanced solutions for CRISPR-based therapeutics, facilitating the development of cell and gene therapies. With a focus on research-use only (RUO) products and regulatory expertise, Synthego supports the entire continuum from discovery to clinical trials, offering a range of CRISPR technologies including gRNA and nucleases. Committed to accelerating life science research and improving human health, Synthego emphasizes high fidelity and affordability in its offerings. Their dedication to regulatory compliance and innovative products, such as the GMP-grade SpCas9 nuclease and essential RNA enzymes, ensures they meet the needs of researchers navigating the complexities of therapeutic development. Generated from the website